Clearbridge Health (SGX:1H3) FCF Margin % : -31.52% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Clearbridge Health's Free Cash Flow for the six months ended in Dec. 2023 was S$-1.84 Mil. Clearbridge Health's Revenue for the six months ended in Dec. 2023 was S$5.83 Mil. Therefore, Clearbridge Health's FCF Margin % for the quarter that ended in Dec. 2023 was -31.52%.

As of today, Clearbridge Health's current FCF Yield % is -55.43%.

The historical rank and industry rank for Clearbridge Health's FCF Margin % or its related term are showing as below:

SGX:1H3' s FCF Margin % Range Over the Past 10 Years
Min: -6118.7 Med: -120.96 Max: 4.22
Current: -35.87

During the past 10 years, the highest FCF Margin % of Clearbridge Health was 4.22%. The lowest was -6118.70%. And the median was -120.96%.

SGX:1H3's FCF Margin % is ranked worse than
63.35% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.47 vs SGX:1H3: -35.87

Clearbridge Health FCF Margin % Historical Data

The historical data trend for Clearbridge Health's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health FCF Margin % Chart

Clearbridge Health Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-48.12

4.22

-33.44

-16.24

-35.87

Clearbridge Health Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial													19.42	-13.50	-19.67	-40.35	-31.52

Competitive Comparison of Clearbridge Health's FCF Margin %

For the Diagnostics & Research subindustry, Clearbridge Health's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearbridge Health's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's FCF Margin % falls into.

Clearbridge Health FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Clearbridge Health's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.122	/	11.49
	=	-35.87 %

Clearbridge Health's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.836	/	5.825
	=	-31.52 %

Clearbridge Health FCF Margin % Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (SGX:1H3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177

Website

https://www.clearbridgehealth.com

Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health (SGX:1H3) Headlines

No Headlines